N/A N=48 Noninvasive Monitoring of Uterine Electrical Activity and Fetal Heart Rate: A New External Monitoring Device
Contraction
Primary: Continuity in Readings of Contractions — 0; 0 Number of minutes — p=0.75
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=35 Refinement of the OBMedical LaborView System
Fetal Monitoring
Primary: Fetal Heart Rate With the Laborview System Versus the CTG Monitor - Pilot Comparison Study — 5.282 beats per minute — p=<.1
Early Phase 1 N=103 Electrode-based Sensor for Non-invasive Fetal Heart Rate and EMG Monitoring With Improved Reliability
Pregnancy
Primary: Comparison of Electrode Sensor and TOCO Detection of Contraction Events, as Compared to IUPC — 2.98; 3.95 seconds
N/A N=71 Electrode-Based Sensor for Non-Invasive Fetal Heart Rate Monitoring With Improved Reliability
Laboring Women With Ultrasound and FSE Monitoring
Primary: Fetal Heart Rate Interpretability — 83.4; 62.4 percentage of time the signals are inter
N/A N=305 Evaluation of the Effects of Different Positions Given During Antenatal Electro-Fetal Monitoring
Fetal Monitoring · Patient Comfort · Maternal Health
Primary: Right Side Lying Post NST (3) — 113.67; 108.16; 112.80 mmHg
N/A N=30 Maternal Fetal Device Performance Singleton
Pregnancy
Primary: Success Rate Calculated Based on Collection of Fetal Heart Rate Data From Investigational Devices on Subjects Enrolled in Each Gestational Age Group — 85.01; 92.27…
N/A N=39 Fetal and Neonatal Magnetophysiology
Fetal Arrhythmia · Abnormality in Fetal Heart Rate or Rhythm · Long QT Syndrome
Primary: Percentage of Subjects Experiencing Symptoms — 0; 0 Participants
N/A N=11,108 Fetal ST Segment and T Wave Analysis in Labor
Pregnancy · Obstetric Labor · Parturition
Primary: Number of Participants With Primary Composite Outcome — 52; 40 Participants — p=0.20
N/A N=121 A Clinical Study for Validating the Equivalence of Bloomlife MFM-Pro to Clinical Standard-of-care for Performing Antepartum Fetal Monitoring
Fetal Monitoring
Primary: Extent of Agreement Between Bloomlife MFM-Pro and CTG in Fetal Heart Rate — -5.46; -5.57; 6.04; 6.04 BPM
N/A N=60 Accuracy and Reliability of Fetal Heart Rate and Uterine Contraction Monitoring Method
Pregnancy; Habitual Aborter · Weeks of Gestation 37 or More
Primary: The Mean Positive Percentage Agreement (PPA) for Fetal Heart Between Device 1 Monica AN24 & Device 2 Philips 50XM — 84.85 Positive percantage agreement (PPA)
N/A N=90 Automated Fetal Heart Echocardiography by Five-Dimensional Ultrasound in the Third Trimester of Pregnancy
Fetal Heart Echocardiography by Five Dimensional Ultrasound
Primary: Number of Satisfactory Fetal Echocardiography Views by Two-Dimensional Ultrasound — 8.7 Number of satisfactory views
N/A N=49 Quantitative End Tidal CO2 Monitoring in the Delivery Room (DR)
Delivery Room Resuscitation
Primary: PCO2 Level Outside of Desired Range (40-60 mmHg) — 9; 8 participants
N/A N=20 Relationship Between EIT and Respiratory Status in Very Preterm Infants
Chronic Lung Disease of Prematurity · Bronchopulmonary Dysplasia · Premature Lungs
Primary: EIT Metric Global Inhomogeneity Index at 31 Weeks Post Menstrual Age in Those Successful in Discontinuation of Non-invasive Ventilation at 32 Weeks Post Menstrual Age…
N/A N=120 Safety and Performance of a Fetal Monitoring System
Pregnancy
Primary: Fetal Heart Rate (FHR) — 140.1; 140.0 BPM
N/A N=55 Medical Grade, Smartphone-based, Fetal Heart Rate Monitor for Outpatient Use
Pregnancy Related
Primary: Device Ease of Use — 72.8; 75.1 score on a scale — p=0.64
N/A N=60 Use Of An In-Home Non-Stress Test Device For Remote Fetal Monitoring
High Risk Pregnancy
Primary: Number of Interpretable Results (Participants Who Used the NST Device Correctly) — 107; 1 Remote NST's Completed — p=.1
N/A N=410 Monitoring Neonatal Resuscitation Trial
Resuscitation · Neonatal Prematurity · Positive-Pressure Respiration
Primary: Percentage of Positive-Pressure Ventilation Inflations Between 4 - 8 Mls/kg — 30.2; 30.7 percentage of inflations — p=0.896
N/A N=65 Continuous Non-Invasive Measurement of Hemoglobin During Parturition
Hemorrhage · Cesarean Section
Primary: Pearson Correlation Coefficient for Hemoglobin Measurements — 0.6 Correlation Coeficient
N/A N=20 Comparison of SureCALL® EMG Labor Monitor® and Tocodynamometer to Intrauterine Pressure Catheter Measurement (IUPC) Measurement in Pregnant Women
Pregnancy - Labor Monitoring
Primary: Comparison of SureCALL® and TOCO Detection of Contraction Events, as Compared to the IUPC — -0.73; -1.74 Seconds — p=.04627
Phase 4 N=602 Prophylactic Ephedrine and Combined Spinal Epidurals for Labor
Labor Pain
Primary: Early Profound Fetal Bradycardia — 8; 14 participants — p=0.18
N/A N=414 The Prevention of Failure to Rescue Using Early Warning Scoring
Sepsis · Renal Failure · Pulmonary Edema
Primary: Survival — 86; 92 percentage of participants
N/A N=195 Home Telemonitoring In Patients After Myocardial Infarction
Myocardial Infarction · Heart Attack
Primary: Emergency Room Visits — 40; 33 Emergency Room Visits
Phase 3 N=794 Tele-Electrocardiography in Emergency Cardiac Care
Myocardial Infarction · Chest Pain
Primary: Hospital Time to Treatment for Patients With Unstable Angina/Non-STEMI — 23; 31 minutes
N/A N=70 Feasibility and Acceptability of the Combination of Propess and AN24 Monica for Outpatient Labour Induction (PRAM)
Intrapartum Fetal Monitoring · Pregnancy
Primary: Feasibility Defined as the Number of Eligible Women Who Are Successfully Monitored Remotely With Trans-abdominal Fetal Electrocardiogram (ECG) Monitoring Device (Monica…
N/A N=2 Vscan Access R2 Feasibility Evaluation
Gather Feasibility Data and User Feedback on Use of a Device in Vivo on Pregnant Volunteers in Their 2nd and 3rd Trimester
Primary: Difference in Fetal Heart Rate as Measured by VScan Access R2 and Corometrics — 4.2 Beats Per Minute (BPM)
N/A N=30 Comparison of SureCALL® Labor Monitor® and Tocodynamometer Measurement in Preterm and Term Pregnant Women
Pregnancy
Primary: Comparison of SureCALL® and Tocodynamometer Detection of Contraction Event Timing — 0.99 Seconds — p=0.4901
N/A N=212 Intrapartum Maternal Oxygen Supplementation: Effects on the Mother and Neonate
Intrauterine Resuscitation
Primary: Umbilical Artery Malondialdehyde — 9.8; 10.2 umol/L
N/A N=25 AF-FLOW Registry to Evaluate Electrographic Flow Mapping in Patients Undergoing Ablation for Atrial Fibrillation
Atrial Fibrillation, Persistent · Atrial Fibrillation · Arrhythmias, Cardiac
Primary: Number of Participants With Acute Procedure Success — 13 Participants
N/A N=80 FLOW-AF: A Study to Evaluate Electrographic Flow™ (EGF) Mapping Technology
Atrial Fibrillation, Persistent
Primary: Number of Participants With Acute Procedure Success — 19 Participants
N/A N=50 TOF Monitoring Using the TetraGraph in Patients Less Than 1 Year of Age
Surgery
Primary: TOFr (%) — 99; 95 percent